MedTrace Logo

Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

NCT06743620 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2025-04-29

No results posted yet for this study

Summary

The main purpose of this registry is to collect observational, long-term safety and effectiveness data in subjects who have received at least one dose of iltamiocel as part of the CLBT clinical study.

Conditions

  • Stress Urinary Incontinence

Interventions

OTHER

iltamiocel

This is an observational study with no intervention.

Sponsors & Collaborators

  • Cook MyoSite

    lead INDUSTRY

Principal Investigators

  • Ron Jankowski, PhD · Cook MyoSite, Inc.

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-11
Primary Completion
2032-04-30
Completion
2032-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06743620 on ClinicalTrials.gov